< Back to previous page
Patent
Treatment of avascular or hypovascular micro-tumors
The invention relates to vascular disrupting agent (VDA) such as combretastatins for treating avascular or hypovascular micro-tumors with a diameter below 20 mm.
Patent Publication Number: EP3648752
Year filing: 2020
Year approval: 2021
Year publication: 2020
Status: Requested
URI: link to Espacenet
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven